María Presa

7PUBLICATIONS
12CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicineSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 13, 2026
Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain.

Sofía de Pedro, María Presa, Josep Gamez

|Aug 10, 2024
The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain.

Raúl Córdoba, Lucía López-Corral, María Presa

|Jul 13, 2024
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain.

Alejandro Martín García-Sancho, María Presa, Carlos Pardo

|Sep 13, 2023
Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain.

María Presa, David Vicente, Antonio Calles

|Feb 15, 2022
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain.

Mariana Bastos-Oreiro, Ana de Las Heras, María Presa

|Feb 06, 2022
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain.

Vicente Estrada, Miguel Górgolas, José A Peña

Pageof 2

Frequent Collaborators

1 joint publications

Mariana Bastos-Oreiro

1 joint publications

Ana de Las Heras

1 joint publications

Laura Salinas-Ortega

1 joint publications

Javier Soto